2020-11-16T07:07:42-06:00 2019-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2019-01-01 521224577 BIOTECHNOLOGY INNOVATION ORGANIZATION BIOT 2029629200 1201 MARYLAND AVE SW NO 900 WASHINGTON DC 20024 STEPHEN JASKO CFO 2029629200 2020-11-14 1 AMY CHAPMAN P00843460 5712279500 2020-11-14 108.48.156.67 2020-11-14 16:35:25 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 87826B80F82B7742AC94E6ED7EC5993094E974B0 2019 2021-04-22 16:20:28Z JAMES C GREENWOOD 1201 MARYLAND AVE SW NO 900 WASHINGTON DC 20024 96457553 0 X WWW.BIO.ORG X 1993 DC SUPPORT THE BIOTECHNOLOGY INDUSTRY AND TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND. 106 106 222 148 1008542 0 0 0 72848062 75437314 2538802 3168579 11923567 13831376 87310431 92437269 2626800 3162700 0 0 36867200 39303857 0 0 0 47030501 53724995 86524501 96191552 785930 -3754283 78940053 84368104 36968656 36733362 41971397 47634742 X THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. 0 0 ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2019 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.THE EMERGING COMPANIES SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES IN THE TAX REFORM DEBATE.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2019 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE.- URGED CONGRESS TO EXTEND A SUITE OF CRITICAL ADVANCED BIOFUELS TAX INCENTIVES BEYOND 2019. SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS APPROXIMATELY 16,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 186 0 222 1 1 1 1 IN 0 0 0 0 1 0 X 106 106 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X STEPHEN JASKO 2029629200 1201 MARYLAND AVENUE SW SUITE 990 WASHINGTON DC 20024 JAMES GREENWOOD PRESIDENT & CHIEF EXECUTIVE OFFICER 40.00 X 2534638 0 154112 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENT 40.00 X 968101 0 16476 THOMAS DILENGE PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY 40.00 X 790497 0 69000 JOANNE DUNCAN PRESIDENT, MEMBERSHIP & BU 40.00 X 770497 0 67121 DANIEL DURHAM EVP, HEALTH POLICY 40.00 X 590657 0 72535 JEANNE HAGGERTY EVP, GOVERMENT AFFAIRS & EXTERNAL RE 40.00 X 518700 0 49350 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 40.00 X 497231 0 75335 ELIZABETH ESHAM EVP, ECS & VP, SCIENCE & REGULATORY 40.00 X 490000 0 52939 YVETTE WHITE-WIGGINS SVP & CHIEF FINANCIAL OFFICER 40.00 X 419301 0 74929 JEREMY LEVIN CHAIR 2.00 X X 0 0 0 JOHN MARAGANORE IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 RON COHEN IMMEDIATE PAST CHAIR (UNTIL 6/19) 2.00 X X 0 0 0 BRADFORD ZAKES TREASURER 2.00 X X 0 0 0 JULIE GERBERDING SECRETARY 2.00 X X 0 0 0 ABBIE CELNIKER DIRECTOR (UNTIL 3/19) 2.00 X 0 0 0 ADAM MONROE DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 ADELENE PERKINS DIRECTOR 2.00 X 0 0 0 ALAN SHAW DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 ALEXANDER HARDY DIRECTOR 2.00 X 0 0 0 ALEXANDER KARNAL DIRECTOR 2.00 X 0 0 0 ALEXANDRIA FORBES DIRECTOR 2.00 X 0 0 0 AMEET MALLIK DIRECTOR 2.00 X 0 0 0 AMIR NASHAT DIRECTOR 2.00 X 0 0 0 ANNA PROTOPAPAS DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 ANNA RATH DIRECTOR 2.00 X 0 0 0 ANNE PHILLIPS DIRECTOR (UNTIL 1/19) 2.00 X 0 0 0 ANNE WHITE DIRECTOR 2.00 X 0 0 0 BARRY FLANNELLY DIRECTOR 2.00 X 0 0 0 BASSIL DAHIYAT DIRECTOR 2.00 X 0 0 0 BERNHARDT ZEIHER DIRECTOR 2.00 X 0 0 0 BILL CAMPBELL DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 BILL SIBOLD DIRECTOR 2.00 X 0 0 0 BOB MORE DIRECTOR 2.00 X 0 0 0 BONNIE ANDERSON DIRECTOR 2.00 X 0 0 0 BRIAN BRAZEAU DIRECTOR 2.00 X 0 0 0 BRIAN THOME DIRECTOR 2.00 X 0 0 0 CARLOS PAYA DIRECTOR (UNTIL 3/19) 2.00 X 0 0 0 CEDRIC FRANCOIS DIRECTOR 2.00 X 0 0 0 CHARL VAN ZYL DIRECTOR 2.00 X 0 0 0 CHRIS STANDLEE DIRECTOR 2.00 X 0 0 0 CHRISTI SHAW DIRECTOR 2.00 X 0 0 0 CHRISTOPHE BOURDON DIRECTOR 2.00 X 0 0 0 CHRISTOPHE SCHILLING DIRECTOR 2.00 X 0 0 0 CHRISTOPHER HEALEY DIRECTOR 2.00 X 0 0 0 CLIVE MEANWELL DIRECTOR (UNTIL 1/19) 2.00 X 0 0 0 DAN MEAGHER DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 DAVID KETTNER DIRECTOR 2.00 X 0 0 0 DAVID MAIN DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 DAVID NICHOLSON DIRECTOR 2.00 X 0 0 0 DAVID STACK DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 DIANE SHANAHAN DIRECTOR 2.00 X 0 0 0 DOUG BERVEN DIRECTOR 2.00 X 0 0 0 DOUGLAS DOERFLER DIRECTOR 2.00 X 0 0 0 EDDIE SULLIVAN DIRECTOR 2.00 X 0 0 0 ELAINE SORG DIRECTOR 2.00 X 0 0 0 ELIZABETH LEWIS DIRECTOR 2.00 X 0 0 0 ERIKA SMITH DIRECTOR 2.00 X 0 0 0 FABRICE CHOURAQUI DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 GAIL MADERIS DIRECTOR 2.00 X 0 0 0 GEORGE SCANGOS DIRECTOR 2.00 X 0 0 0 GIL VAN BOKKELEN DIRECTOR 2.00 X 0 0 0 GREGG ALTON DIRECTOR (UNTIL 10/19) 2.00 X 0 0 0 H THOMAS WATKINS DIRECTOR (UNTIL 11/19) 2.00 X 0 0 0 HELEN TORLEY DIRECTOR 2.00 X 0 0 0 HOWARD ROBIN DIRECTOR 2.00 X 0 0 0 HUGH WELSH DIRECTOR 2.00 X 0 0 0 JAMES SAPIRSTEIN DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 JEAN-JACQUES BIENAIME DIRECTOR 2.00 X 0 0 0 JEFF KINDLER DIRECTOR 2.00 X 0 0 0 JEFFREY CLELAND DIRECTOR 2.00 X 0 0 0 JEFFREY MARRAZZO DIRECTOR 2.00 X 0 0 0 JENNIFER HOLMGREN DIRECTOR 2.00 X 0 0 0 JENNIFER TAUBERT DIRECTOR 2.00 X 0 0 0 JILL ZULLO DIRECTOR 2.00 X 0 0 0 JOHN CROWLEY DIRECTOR 2.00 X 0 0 0 JOHN LEPORE DIRECTOR 2.00 X 0 0 0 JOHN MELO DIRECTOR 2.00 X 0 0 0 JOHN OYLER DIRECTOR 2.00 X 0 0 0 JOHN YOUNG DIRECTOR 2.00 X 0 0 0 JOSEPH LAROSA DIRECTOR 2.00 X 0 0 0 JOSHUA OFMAN DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 JULIA OWENS DIRECTOR 2.00 X 0 0 0 JUSTIN GOVER DIRECTOR 2.00 X 0 0 0 KARSTEN TEMME DIRECTOR 2.00 X 0 0 0 KATRINE BOSLEY DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 KENNETH MOCH DIRECTOR 2.00 X 0 0 0 KEVIN GORMAN DIRECTOR 2.00 X 0 0 0 KIRAN MAZUMDAR-SHAW DIRECTOR (UNTIL 1/19) 2.00 X 0 0 0 LAURA BEREZIN DIRECTOR 2.00 X 0 0 0 LONNIE MOULDER DIRECTOR (UNTIL 1/19) 2.00 X 0 0 0 MARK DROZDOWSKI DIRECTOR 2.00 X 0 0 0 MARK ENYEDY DIRECTOR 2.00 X 0 0 0 MARK PLATT DIRECTOR 2.00 X 0 0 0 MARK PRUZANSKI DIRECTOR 2.00 X 0 0 0 MARK TIMNEY DIRECTOR 2.00 X 0 0 0 MARK TRUDEAU DIRECTOR 2.00 X 0 0 0 MARTIN BABLER DIRECTOR 2.00 X 0 0 0 MEENU CHHABRA DIRECTOR 2.00 X 0 0 0 MICHAEL MORRISSEY DIRECTOR 2.00 X 0 0 0 MICHAEL NARACHI DIRECTOR 2.00 X 0 0 0 MICHAEL RAAB DIRECTOR 2.00 X 0 0 0 MICHAEL RYAN DIRECTOR 2.00 X 0 0 0 NANCY SIMONIAN DIRECTOR 2.00 X 0 0 0 NICK LESCHLY DIRECTOR 2.00 X 0 0 0 OLIVER WALKER DIRECTOR 2.00 X 0 0 0 PAIGE MAHANEY DIRECTOR 2.00 X 0 0 0 PATRICK GRUBER DIRECTOR 2.00 X 0 0 0 PAUL HASTINGS DIRECTOR 2.00 X 0 0 0 PAUL MCKENZIE DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 PERRY STERNBERG DIRECTOR (UNTIL 1/19) 2.00 X 0 0 0 PHILIP MILLER DIRECTOR 2.00 X 0 0 0 RACHEL KING DIRECTOR 2.00 X 0 0 0 RICHARD PAULSON DIRECTOR 2.00 X 0 0 0 RICHARD POPS DIRECTOR 2.00 X 0 0 0 RICK TURNER DIRECTOR 2.00 X 0 0 0 RICK WINNINGHAM DIRECTOR 2.00 X 0 0 0 ROBERT WALSH DIRECTOR 2.00 X 0 0 0 ROBERT WILLS DIRECTOR 2.00 X 0 0 0 ROGER WYSE DIRECTOR 2.00 X 0 0 0 RONALD STOTISH DIRECTOR (UNTIL 6/19) 2.00 X 0 0 0 RUSSELL HERNDON DIRECTOR 2.00 X 0 0 0 SANDY MACRAE DIRECTOR 2.00 X 0 0 0 SCOTT HOLMSTROM DIRECTOR 2.00 X 0 0 0 SCOTT KOENIG DIRECTOR 2.00 X 0 0 0 SEBASTIAN GUTH DIRECTOR 2.00 X 0 0 0 SHAJI PROCIDA DIRECTOR 2.00 X 0 0 0 SHARON MATES DIRECTOR 2.00 X 0 0 0 SHEILA GUJRATHI DIRECTOR 2.00 X 0 0 0 STEVE ALBERS DIRECTOR 2.00 X 0 0 0 STEVEN MENTO DIRECTOR (UNTIL 8/19) 2.00 X 0 0 0 STUART ARBUCKLE DIRECTOR 2.00 X 0 0 0 SUE WASHER DIRECTOR 2.00 X 0 0 0 SYLVIA WULF DIRECTOR 2.00 X 0 0 0 TAMMY LEE DIRECTOR (UNTIL 7/19) 2.00 X 0 0 0 TED LOVE DIRECTOR 2.00 X 0 0 0 TERRIE CURRAN DIRECTOR (UNTIL 12/19) 2.00 X 0 0 0 THOMAS WIGGANS DIRECTOR 2.00 X 0 0 0 TIMOTHY WALBERT DIRECTOR 2.00 X 0 0 0 WILLIAM FITZSIMMONS DIRECTOR (UNTIL 3/19) 2.00 X 0 0 0 WILLIAM NEWELL DIRECTOR 2.00 X 0 0 0 7579622 0 631797 98 0 1 0 FREEMAN EXPOSITIONS PO BOX 660613 DALLAS TX 75266 CONVENTION & CONFERENCES CONTRACTOR 2785194 SUBJECT MATTER 1201 NEW YORK AVENUE NW WASHINGTON DC 20005 CONSULTING SERVICES 1841510 DANIEL J EDELMAN INC 200 E RANDOLPH DRIVE SUITE 6300 CHICAGO IL 60601 CONSULTING SERVICES 1834164 ARAMARK 1101 ARCH STREET PHILADELPHIA PA 19107 CONVENTION CENTER RENTAL 1321436 THE HERALD GROUP LLC 1800 M STREET NW SUITE 450 SOUTH WASHINGTON DC 20036 CONVENTION CENTER RENTAL 1200000 111 CONFERENCE/MEETING REVENUE 541800 41042359 40591159 451200 MEMBERSHIP DUES 900099 29773139 29773139 EPF MEMBER SUPPORT 900099 3791882 3791882 LEGAL & POLICY SUPPORT 900099 764449 764449 ALLIANCE/OUTREACH SUPPORT 900099 37000 37000 28485 28485 75437314 2573466 2573466 13788489 549842 13238647 8800 8800 0 4606597 4011484 595113 595113 595113 BIONEWS ADS INCOME 541800 7500 7500 35387 35387 42887 92437269 74986114 1008542 16442613 X 3162700 4880095 26392429 2320083 4086479 1624771 249312 77016 4574874 65114 15240690 407570 595204 1130035 3908026 1838936 16979149 10612 5614298 541255 131633 DUES & SUBSCRIPTIONS 1213530 TAXES PAID 544807 OUTREACH 343241 BIO LEGISLATIVE DAY/FLY 219693 40000 96191552 6430187 3112278 3364536 1164890 4302636 4901799 2635707 2684754 8263569 6938698 1088918 1324871 61118069 71179512 78940053 84368104 18759698 18918891 15113063 15579354 3095895 2235117 36968656 36733362 X 41971397 47634742 41971397 47634742 78940053 84368104 X -3754283 9289428 128200 X 0 1 X 1 0 0 0 1 29773139 12210000 263328 12473328 12206987 266341 6258352 5950712 307640 276745 200020 76725 1728472 787966 940506 1324871 CAPITAL LEASE OBLIGATION 82392 DEFERRED RENT 2152725 2235117 103696240 9289428 2025857 11315285 92380955 65114 -8800 56314 92437269 98032895 2004657 2004657 96028238 65114 98200 163314 96191552 PART XI, LINE 2D - OTHER ADJUSTMENTS: BIOSIMILARS REVENUE 80,000. FGR SPECIAL INITIATIVES REVENUE 913,306. CBI LOBBYING FUND 1,032,551. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES -8,800. PART XII, LINE 2D - OTHER ADJUSTMENTS: FOOD & AG LEGAL FUND EXPENSES BIOSIMILAR EXPENSES 80,000. FGR SPECIAL INITIATIVE EXPENSES 913,306. FOOD & AG SGR FUND 1,002,551. RENTAL EXPENSES 8,800. PART XII, LINE 4B - OTHER ADJUSTMENTS: DEFERRED SPONSORSHIP EXPENSE 98,200. 1 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 3 PROGRAM SERVICES CONFERENCES, ADVOCACY 492487 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 2 PROGRAM SERVICES CONFERENCES, ADVOCACY AND EDUCATION 301291 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, 0 1 PROGRAM SERVICES ADVOCACY 10073 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 1 2 PROGRAM SERVICES CONFERENCES, ADVOCACY 4664 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 1 PROGRAM SERVICES ADVOCACY 121670 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 0 PROGRAM SERVICES ADVOCACY 22365 SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, 0 0 PROGRAM SERVICES ADVOCACY 11898 1 9 0 0 1 9 964448 0 964448 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES. PART III ACCOUNTING METHOD: 1 ADAP ADVOCACY ASSOCIATION PO BOX 846 NAGS HEAD NC 27959 260482120 501(C)(3) 6000 SCHOLARSHIP ALLIANCE FOR AGING RESEARCH 1700 K STREET NW SUITE 740 WASHINGTON DC 20006 541379174 501(C)(3) 15000 SPONSORSHIP ALLIANCE TO PROTECT MEDICAL INNOVATION 1220 L ST NW SUITE 100 488 WASHINGTON DC 20005 831354631 501(C)(4) 160000 CONTRIBUTION AMERICAN ACTION FORUM 1747 PENNSYLVANIA AVE NW 5TH FLOOR WASHINGTON DC 20006 270567765 501(C)(3) 75000 CONTRIBUTION AMERICAN CANCER SOCIETY ACTION NETWORK INC 555 11TH STREET SUITE 300 WASHINGTON DC 20004 522340031 501(C)(4) 10000 SPONSORSHIP AMERICAN CANCER SOCIETY ACTION NETWORK INC 555 11TH STREET SUITE 300 WASHINGTON DC 20004 522340031 501(C)(4) 25000 GENERAL SUPPORT AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH 1789 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 530218495 501(C)(3) 30000 GENERAL SUPPORT ARIZONA BIOINDUSTRY ASSOCIATION 107 S SOUTHGATE DRIVE CHANDLER AZ 85226 860938465 501(C)(6) 15000 SPONSORSHIP ARTHRITIS FOUNDATION INC 1355 PEACHTREE ST 600 ATLANTA GA 30309 581341679 501(C)(3) 15000 SPONSORSHIP ARTHRITIS FOUNDATION INC 1355 PEACHTREE ST 600 ATLANTA GA 30309 581341679 501(C)(3) 47000 GENERAL SUPPORT ASSOCIATION OF AMERICAN VETERINARY MEDICAL COLLEGES 655 K ST NW SUITE 725 WASHINGTON DC 20001 366144553 501(C)(3) 25000 SPONSORSHIP AUTOIMMUNE DISEASE ASSOCIATION 22100 GRATIOT AVE EASTPOINTE MI 480212227 383027574 501(C)(3) 10000 GENERAL SUPPORT BIO FLORIDA 6742 FOREST HILL BLVD SUITE 256 WEST PALM BEACH FL 33413 593436638 501(C)(6) 5500 SPONSORSHIP BIO NEBRASKA LIFE SCIENCES ASSOCIATION PO BOX 24802 OMAHA NE 68124 202214508 501(C)(6) 6000 SPONSORSHIP BIONJ INC 1255 WHITEHORSE-MERCERVILLE RD BUILDING B - SUITE 514 TRENTON NJ 08619 223284393 501(C)(6) 50000 SPONSORSHIP BIOOHIO 1275 KINNEAR RD COLUMBUS OH 43212 341577705 501(C)(3) 10000 SPONSORSHIP CALIFORNIA LIFE SCIENCES ASSOCIATION 9191 TOWNE CENTRE DRIVE SUITE 450 SAN DIEGO CA 92122 473226523 501(C)(6) 300000 GENERAL SUPPORT CANCER SUPPORT COMMUNITY 734 15TH STREET NW SUITE 300 WASHINGTON DC 20005 954163931 501(C)(3) 25000 GENERAL SUPPORT CAPITAL CLUBHOUSE INC 80 M ST SE 1ST FLOOR WASHINGTON DC 20003 454366185 501(C)(3) 10000 SPONSORSHIP CENTER FOR FOOD INTEGRITY 2900 NE BROOKTREE LANE SUITE 200 GLADSTONE MO 64119 204662713 501(C)(4) 25000 GENERAL SUPPORT CENTER FOR MEDICINE IN THE PUBLIC INTEREST 757 THIRD AVENUE 20TH FLOOR NEW YORK NY 10017 204321812 501(C)(3) 25000 GENERAL SUPPORT COLORADO BIOSCIENCE ASSOCIATION 600 GRANT STREET SUITE 306 DENVER CO 80203 841363258 501(C)(6) 10000 SPONSORSHIP CYSTIC FIBROSIS FOUNDATION 4550 MONTGOMERY AVENUE SUITE 350N BETHESDA MD 20814 131930701 501(C)(3) 7500 SPONSORSHIP DELAWARE BIOSCIENCE ASSOCIATION 1 INNOVATION WAY SUITE 300 NEWARK DE 19711 204147195 501(C)(6) 15000 SPONSORSHIP DEMOCRATIC GOVERNORS ASSOCIATION 1401 K ST NW SUITE 200 WASHINGTON DC 20005 521304889 N/A 25000 CONTRIBUTION EPILEPSY FOUNDATION 8301 PROFESSIONAL PLACE EAST SUITE 200 LANDOVER MD 207852353 520856660 501(C)(3) 15000 GENERAL SUPPORT EVERYLIFE FOUNDATION FOR RARE DISEASES 1012 14TH ST NW SUITE 500 WASHINGTON DC 20005 264614274 501(C)(3) 10000 SPONSORSHIP GLOBAL DOWN SYNDROME FOUNDATION 3239 E 2ND AVE DENVER CO 80206 264431001 501(C)(3) 6000 SPONSORSHIP GLOBAL GENES 28 ARGONAUT SUITE 150 ALISO VIEJO CA 92656 263331487 501(C)(3) 10000 GENERAL SUPPORT HAWAII FARM BUREAU FEDERATION PO BOX 253 KUNIA HI 96759 990073460 501(C)(5) 22500 GENERAL SUPPORT HEALTHCARE READY 1325 G ST NW SUITE 500 WASHINGTON DC 20005 463134601 501(C)(3) 10000 CONTRIBUTION HEALTHY WOMEN 1 HARDING RD SUITE 102A RED BANK NJ 07701 521624846 501(C)(3) 20000 SPONSORSHIP INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION 1101 K ST NW SUITE 610 WASHINGTON DC 20005 204403497 501(C)(3) 60000 GENERAL SUPPORT INSTITUTE FOR PATIENT ACCESS PO BOX 670 BETTENDORF IA 52722 453456087 501(C)(3) 30000 GENERAL SUPPORT INSTITUTE FOR POLICY INNOVATION 1320 GREENWAY DR SUITE 820 IRVING TX 75038 752158093 501(C)(3) 15000 GENERAL SUPPORT INSTITUTE ON SCIENCE FOR GLOBAL POLICY 13630 E SAHUARO SUNSET RD TUCSON AZ 85749 453998749 501(C)(3) 20000 GENERAL SUPPORT IOWA BIOTECH ASSOCIATION 900 E DES MOINES ST DES MOINES IA 50309 391885797 501(C)(6) 15000 GENERAL SUPPORT JDRF INTERNATIONAL 1400 K STREET NW SUITE 725 WASHINGTON DC 20005 231907729 501(C)(3) 10000 SPONSORSHIP KEYSTONE POLICY CENTER 1628 SAINTS JOHN ROAD KEYSTONE CO 80435 840688506 501(C)(3) 20000 GENERAL SUPPORT LEUKEMIA & LYMPHOMA SOCIETY 3601 EISENHOWER AVENUE SUITE 450 ALEXANDRIA VA 22304 135644916 501(C)(3) 10000 SPONSORSHIP LOUISIANABIO 1441 CANAL STREET NEW ORLEANS LA 70112 273567932 N/A 20000 GENERAL SUPPORT LUNGEVITY FOUNDATION 228 S WABASH AVE SUITE 700 CHICAGO IL 60604 364433410 501(C)(3) 20000 GENERAL SUPPORT LUPUS FOUNDATION OF AMERICA INC 2121 K STREET NW SUITE 200 WASHINGTON DC 20037 431131436 501(C)(3) 309000 GENERAL SUPPORT MASSACHUSETTS BIOTECHNOLOGY COUNCIL 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 222693047 501(C)(6) 7500 SPONSORSHIP MONTANA BIOSCIENCE ALLIANCE P O BOX 1773 BILLINGS MT 59103 201647600 501(C)(6) 15000 GENERAL SUPPORT NATIONAL ASSOCIATION OF STATE DEPARTMENT OF AGRICULTURE (NASDA) 4350 N FAIRFAX DR SUITE 910 ARLINGTON VA 22203 520845105 501(C)(6) 12500 SPONSORSHIP NATIONAL BLACK CHURCH INITIATIVE POBOX 65177 WASHINGTON DC 20035 522169774 N/A 25000 GENERAL SUPPORT NATIONAL COALITION FOR CANCER SURVIVORSHIP 8455 COLESVILLE ROAD SUITE 930 SILVER SPRING MD 20910 850357897 501(C)(3) 10000 SPONSORSHIP NATIONAL CONFERENCE OF STATE LEGISLATURES 7700 EAST FIRST PLACE DENVER CO 80230 840772595 N/A 22000 SPONSORSHIP NATIONAL FARMERS UNION 20 F STREET NW 300 WASHINGTON DC 20001 840200555 501(C)(3) 10000 SPONSORSHIP NATIONAL HEALTH COUNCIL 1730 M STREET NW SUITE 500 WASHINGTON DC 20036 131624107 501(C)(3) 15000 SPONSORSHIP NATIONAL PSORIASIS FOUNDATION 6600 SW 92ND AVE SUITE 300 PORTLAND OR 97223 930571472 501(C)(3) 15000 GENERAL SUPPORT NCSL FOUNDATION FOR STATE LEGISLATURES 7700 EAST FIRST PLACE DENVER CO 80230 742232576 501(C)(3) 7500 SPONSORSHIP NEW YORK BIOTECHNOLOGY ASSOCIATION 25 HEALTH SCIENCES DR SUITE 203 STONY BROOK NY 11790 113026494 501(C)(6) 25000 SPONSORSHIP ONE NATION 45 N HILL DRIVE SUITE 100 WARRENTON VA 20186 271937961 501(C)(4) 250000 GENERAL SUPPORT OREGON BIOSCIENCE ASSOCIATION 2828 SW CORBETT AVE SUITE 115 PORTLAND OR 97201 931009329 501(C)(6) 20000 SPONSORSHIP OREGON BIOSCIENCE ASSOCIATION 2828 SW CORBETT AVE SUITE 115 PORTLAND OR 97201 931009329 501(C)(6) 10000 GENERAL SUPPORT ORRIN G HATCH FOUNDATION 411 E SOUTH TEMPLE SALT LAKE CITY UT 84111 474823732 501(C)(3) 25000 SPONSORSHIP PERSONALIZED MEDICINE COALITION 1225 NEW YORK AVE SUITE 450 WASHINGTON DC 20005 542134884 501(C)(3) 20000 SPONSORSHIP PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 950 F STREET NW SUITE 300 WASHINGTON DC 20004 530241211 501(C)(6) 40000 GENERAL SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE ST SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 7000 SPONSORSHIP RARE ACCESS ACTION PROJECT PO BOX 2756 PURCELLVILLE VA 20134 824433613 501(C)(4) 10000 GENERAL SUPPORT RI BIO PO BOX 5680 53 BROAD ST PROVIDENCE RI 02903 462858053 501(C)(6) 6000 SPONSORSHIP SICK CELLS 4512 RIVER DRIVE LISLE IL 60532 813481633 501(C)(3) 10000 SPONSORSHIP SOCIETY FOR WOMEN'S HEALTH RESEARCH 1025 CONNECTICUT AVE NW SUITE 601 WASHINGTON DC 20036 521694732 501(C)(3) 15000 SPONSORSHIP STATE AGRICULTURE AND RURAL LEADERS 21547 HWY 527 ALDEN IA 50006 204400600 501(C)(3) 7500 SPONSORSHIP STATE OF REFORM 19101 36TH AVE W 203 LYNNWOOD WA 98036 201502691 N/A 8200 SPONSORSHIP THE AIDS INSTITUTE 17 DAVIS BLVD SUITE 403 TAMPA FL 33606 650380952 501(C)(3) 15000 GENERAL SUPPORT THE GALIEN FOUNDATION INC 99 JOHN STREET SUITE 2502 NEW YORK NY 10038 264549935 501(C)(3) 15000 SPONSORSHIP TRUSTEES OF TUFTS COLLEGE 75 KNEELAND ST SUITE 1100 TUFTS UNIVERSITY BOSTON MA 02111 042103634 501(C)(3) 12000 SPONSORSHIP US - INDIA STRATEGIC PARTNERSHIP INC 2550 M STREET NW WASHINGTON DC 20037 822265517 501(C)(6) 15000 SPONSORSHIP US CHAMBER OF COMMERCE 1615 H STREET NW PO BOX 1200 WASHINGTON DC 20062 530045720 501(C)(6) 875000 GENERAL SUPPORT US CHAMBER OF COMMERCE 1615 H STREET NW PO BOX 1200 WASHINGTON DC 20062 530045720 501(C)(6) 50000 CONTRIBUTION VIRGINIA BIOTECHNOLOGY ASSOCIATION 800 E LEIGH ST SUITE 14 RICHMOND VA 23219 541644709 501(C)(6) 18000 SPONSORSHIP 42 32 PART I, LINE 2: BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED. X X X 0 1 X X X X X 1 1 0 JAMES GREENWOOD PRESIDENT & CHIEF EXECUTIVE OFFICER 1623823 0 910815 0 0 0 37000 0 117112 0 2688750 0 0 0 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENT 522375 0 119400 0 326326 0 6070 0 10406 0 984577 0 0 0 THOMAS DILENGE PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC 550000 0 240497 0 0 0 37000 0 32000 0 859497 0 0 0 JOANNE DUNCAN PRESIDENT, MEMBERSHIP & BU 530000 0 240497 0 0 0 37000 0 30121 0 837618 0 0 0 DANIEL DURHAM EVP, HEALTH POLICY 464410 0 126247 0 0 0 37000 0 35535 0 663192 0 0 0 JEANNE HAGGERTY EVP, GOVERMENT AFFAIRS & EXTERNAL RE 401700 0 117000 0 0 0 35537 0 13813 0 568050 0 0 0 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 385074 0 112157 0 0 0 37000 0 38335 0 572566 0 0 0 ELIZABETH ESHAM EVP, ECS & VP, SCIENCE & REGULATORY 371000 0 119000 0 0 0 37000 0 15939 0 542939 0 0 0 YVETTE WHITE-WIGGINS SVP & CHIEF FINANCIAL OFFICER 296717 0 104000 0 18584 0 37785 0 37144 0 494230 0 0 0 PART I, LINE 1A INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL -FIRST CLASS OR CHARTER TRAVEL - $2,580 -TRAVEL FOR COMPANIONS - $1,004 PART I, LINE 1B THE CHIEF EXECUTIVE OFFICER HAS A PREPAID SPENDING ACCOUNT AT A LOCAL RESTAURANT, USED EXCLUSIVELY FOR BUSINESS PURPOSES. PART I, LINES 4A-B BRENT ERICKSON - SEVERANCE PAYMENT - $398,000 BRENT ERICKSON - 457B PAYOUT - $326,326 MATT LOWE - 457B PAYOUT - $3,885 JAMES GREENWOOD - 457(F) CONTRIBUTION - $727,517 LAURA GREENWOOD DAUGHTER OF CEO 79127 PAID EMPLOYEE OF ORGANIZATION 0 LILY DOEFLER DAUGHTER OF A BOARD MEMBER 59777 PAID EMPLOYEE OF ORGANIZATION 0 FORM 990, PART VI, SECTION A, LINE 1 THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, DIVISION PRESIDENTS, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. FORM 990, PART VI, SECTION B, LINE 15 FOR 2019, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2019, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE PRESIDENTS OF THE TWO DIVISIONS AT BIO LED THE PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART IX, LINE 11G EC EMERGING PRIORITIES 13,212,145. WORKPLAN OBJECTIVES 149,698. I&E INITIATIVES 1,027. INTERNS 46,485. TEMPORARY HELP 175,501. CEO DELEGATION EXPENSE 22,804. ECONOMIC STUDIES 764,241. CONSULTANTS AND OTHER PROFESSIONAL FEES 401,459. BIO-PAC ADMINISTRATIVE 34,513. BUSINESS DEVELOPMENT EXEC PRESENTATION 60,018. PROGRAM INITIATIVES 39,280. RECRUITMENT 208,835. BUSINESS STRATEGIES 33,391. EDUCATION 91,293. FORM 990, PART XI, LINE 9: DEFERRED SPONSORSHIP EXPENSE 98,200. NET EXCLUSIVE BUSINESS SOLUTION 30,000. EXCELLENCE THROUGH STEWARDSHIP 1201 MARYLAND AVE SW SUITE 900 WASHINGTON DC 20024 263021330 TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE PROMISE, ACHIEVEMENTS DC 501(C)(4) 0 BIOTECHNOLOGY INSTITUTE 1201 MARYLAND AVE SW SUITE 900 WASHINGTON DC 20024 251716917 TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE CHALLENGES OF BIOTECH. DC 501(C)(3) LINE 7 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0